Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,395

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

The Rotterdam Study: objectives and design update

Open access
Hofman, Albert, Breteler, Monique M. B., van Duijn, Cornelia M., Krestin, Gabriel P., Pols, Huibert A., Stricker, Bruno H. Ch., Tiemeier, Henning, Uitterlinden, André G., Vingerling, Johannes R., Witteman, Jacqueline C. M.·2007·European Journal of Epidemiology
DOI 10.1007/s10654-007-9199-x
Open this paper in CoChat — free account

Abstract

The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of Rotterdam in The Netherlands. The study targets cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, otolaryngological, locomotor, and respiratory diseases. As of 2008, 14,926 subjects aged 45 years or over comprise the Rotterdam Study cohort. The findings of the Rotterdam Study have been presented in over 1200 research articles and reports (see www.erasmus-epidemiology.nl/rotterdamstudy ). This article gives the rationale of the study and its design. It also presents a summary of the major findings and an update of the objectives and methods.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10654-007-9199-x

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Research works printed but not linked: 79

  1. Oeppen J, Vaupel JW. Broken limits to life expectancy. Science 2002;296:1029–31. · DOI · Paper page
  2. Peto R, Doll R. There is no such thing as aging. BMJ 1997;315:1030–2. · DOI
  3. Hofman A, Grobbee DE, de Jong PTVM, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Study. Eur J Epidemiol 1991;7:403–22. · DOI · Paper page
  4. Hak AE, Pols HAP, Visser TJ, Drexhage HA, Hofman A, Witteman JCM. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000;132:270–8. · DOI · Paper page
  5. Schuit SCE, Oei HHS, Witteman JCM, Geurts Van Kessel CH, Van Meurs JBJ, Nijhuis RL, Van Leeuwen JPTM, De Jong FH, Zillekens MC, Hofman A, Pols HAP, Uitterlinden AG. Estrogen receptor α gene polymorphisms and risk of myocardial infarction. JAMA 2004;291:2969–77. · DOI · Paper page
  6. Kardys I, De Maat MP, Uitterlinden AG, Hofman A, Witteman JC. C-reactive protein gene haplotypes and risk of coronary heart disease. The Rotterdam Study. Eur Heart J 2006;27:1331–7. · DOI
  7. Oei HH, Van der Meer IM, Hofman A, Koudstaal PJ, Stijnen T, Breteler MM, Witteman JC. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation 2005;111:570–5. · DOI · Paper page
  8. Kardys I, Klaver CC, Despriet DD, Bergen AA, Uitterlinden AG, Hofman A, Oostra BA, Van Duijn CM, De Jong PT, Witteman JC. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction. The Rotterdam Study. J Am Coll Cardiol 2006;47:1568–75. · DOI
  9. Van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 2004;109:1089–94. · DOI · Paper page
  10. Vliegenthart R, Oudkerk M, Hofman A, Oei HHS, van Dijck W, van Rooij F, Witteman JCM. Coronary calcification improves cardiovascular risk prediction in a population of older adults. Circulation 2005;112:572–7. · DOI · Paper page
  11. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure the Rotterdam Study. Eur Heart J 2004;25:1614–9. · DOI
  12. Heeringa J, van der Kuip DAM, Hofman A, Kors JA, van Rooij FJA, Lip GYH, Witteman JCM. Subclinical atherosclerosis and risk of atrial fibrillation. Arch Intern Med 2007;167:382–7. · DOI
  13. Van Vark LC, Kardys I, Bleumink GS, Knetsch AM, Deckers JW, Hofman A, Stricker BH, Witteman JC. Lipoprotein-associated phospholipase A2 activity and risk of heart failure: the Rotterdam study. Eur Heart J 2006;27:2346–52. · DOI
  14. Ott A, Breteler MMB, van Harskamp F, Claus JJ, van der Cammen TJM, Grobbee DE, Hofman A. Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam study. BMJ 1995;310:970-3. · DOI · Paper page
  15. de Rijk MC, Breteler MMB, Graveland GA, Ott A, Grobbee DE, van der Meché FGA, Hofman A. Prevalence of Parkinson’s disease in the elderly. The Rotterdam Study. Neurology 1995;45:2143-6. · DOI · Paper page
  16. Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MMB. Incidence of dementia: does gender make a difference? Neurobiol Aging 2001;22:575–80. · DOI · Paper page
  17. de Lau LML, Giesbergen PCLM, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MMB. Incidence of parkinsonism and Parkinson’s disease in a general population: the Rotterdam Study. Neurology 2004;63:1240–4. · DOI · Paper page
  18. Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MMB. Incidence, risk and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry 2003;74:317–21. · DOI · Paper page
  19. Breteler MMB, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and the distribution of cognitive function in an elderly population. The Rotterdam Study. BMJ 1994;308:1604–8. · DOI · Paper page
  20. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, van Harskamp F, van Duijn CM, van Broeckhoven C, Grobbee DE. Atherosclerosis, apolipoprotein E and the prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet 1997;349:151–4. · DOI · Paper page
  21. Ott A, Slooter AJC, Hofman A, van Harskamp F, Witteman JCM, van Broeckhoven C, van Duijn CM, Breteler MMB. Smoking and risk of dementia and Alzheimer’s disease in a population-based cohort study: the Rotterdam Study. Lancet 1998;351:1840–3. · DOI · Paper page
  22. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JCM, Breteler MMB. Dietary intake of antioxidants and risk of Alzheimer’s disease: the Rotterdam Study. JAMA 2002;287:3223–9. · DOI · Paper page
  23. Ruitenberg A, van Swieten JC, Witteman JCM, Mehta KM, van Duijn CM, Hofman A, Breteler MMB. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet 2002;359:281–6. · DOI · Paper page
  24. Hollander M, Bots ML, Iglesias del Sol A, Koudstaal PJ, Witteman JCM, Grobbee DE, Hofman A, Breteler MMB. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam Study. Circulation 2002;105:2872–7. · DOI · Paper page
  25. Bos MJ, Schipper CMA, Koudstaal PJ, Witteman JCM, Hofman A, Breteler MM. High plasma C-reactive protein level is not an independent predictor for stroke. The Rotterdam Study. Circulation 2006;114:1591–8. · DOI
  26. Vernooij MW, Ikram MA, Tanghe HL, Vincent AJPE, Hofman A, Krestin GP, Niessen WJ, Breteler MMB, Van der Luyt A. Incidental findings on brain MRI in the general population N Engl J Med 2007 (in press). · DOI · Paper page
  27. de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MMB. Cerebral white matter lesions and depressive symptoms in elderly adults. Arch Gen Psychiatry 2000;57:1071–6. · DOI · Paper page
  28. Den Heijer T, Geerlings MI, Hoebeek FE, Hofman A, Koudstaal PJ, Breteler MMB. Use of hippocampal and amygdalar volumes on MRI to predict dementia in cognitively intact elderly people. Arch Gen Psychiatry 2006;63:57–62. · DOI · Paper page
  29. Breteler MMB, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JHW, van Harskamp F, Tanghe HLJ, de Jong PTVM, van Gijn J, Hofman A. Cerebral white matter lesions, vascular risk factors and cognitive function in a population-based study. Neurology 1994;44:1246-52. · DOI · Paper page
  30. Tiemeier H, Dijck van W, Hofman A, Witteman JCM, Stijnen T, Breteler MMB. Atherosclerosis and late life depression are related. The Rotterdam Study. Arch Gen Psychiatry 2004;61:369–76. · DOI · Paper page
  31. Tiemeier H, Bakker SLM, Hofman A, Koudstaal PJ, Breteler MMB. Cerebral haemodynamics and depression in the elderly. J Neurol Neurosurg Psychiatry 2002;73:34–39. · DOI
  32. Naarding P, Tiemeier H, Breteler MM, Schoevers RA, Jonker C, Koudstaal PJ, Beekman AT. Clinically defined vascular depression in the general population. Psychol Med 2007;37:383–92. · DOI
  33. Tiemeier H, van Tuijl HR, Hofman A, Kiliaan AJ, Breteler MMB. Plasma fatty acid composition and depression in the elderly are associated: the Rotterdam Study. Am J Clin Nutr 2003;78:40–6. · DOI · Paper page
  34. Tiemeier H, Hofman A, Kiliaan AJ, Meijer J, Breteler MMB. Vitamin E and depressive symptoms are not related. The Rotterdam Study. J Affect Disord 2002;72:79–83. · DOI
  35. Tiemeier H, Hofman A, van Tuijl HR, Kiliaan AJ, Meijer J, Breteler MMB. Inflammatory proteins and depression in the elderly. Epidemiology 2003;14:103–7. · DOI · Paper page
  36. Tiemeier H, Schuit SC, den Heijer T, van Meurs JB, van Tuijl HR, Hofman A, Breteler MM, Pols HA, Uitterlinden AG. Estrogen receptor alpha gene polymorphisms and anxiety disorder in an elderly population. Mol Psychiatry 2005;10:806–7. · DOI
  37. van den Berg JF, Tulen JHM, Neven AK, Hofman A, Miedema HME, Witteman JCM, Tiemeier H. Sleep duration and hypertension are not associated in the elderly. Hypertension 2007;50:585–9. · DOI · Paper page
  38. Prigerson HG, Maciejewski PK, Reynolds CF 3rd, Bierhals AJ, Newsom JT, Fasiczka A, Frank E, Doman J, Miller M. Inventory of complicated grief: a scale to measure maladaptive symptoms of loss. Psychiatry Res 1995;59:65–79. · DOI · Paper page
  39. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol 1998;116:653–8. · DOI · Paper page
  40. Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995;142:404–9. · DOI · Paper page
  41. Ikram MK, van Leeuwen R, Vingerling JR, Hofman A, de Jong PT. Relationship between refraction and prevalent as well as incident age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci 2003;44:3778–82. · DOI
  42. Klaver CC, Kliffen M, van Duijn CM, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998;63:200–6. · DOI · Paper page
  43. Klaver CC, Wolfs RC, Assink JJ, van Duijn CM, Hofman A, de Jong PT. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 1998;116:1646–51. · DOI · Paper page
  44. Assink JJ, Klaver CC, Houwing-Duistermaat JJ, et al. Heterogeneity of the genetic risk in age-related macular disease: a population-based familial risk study. Ophthalmology 2005;112:482–7. · DOI
  45. van Leeuwen R, Vingerling JR, Hofman A, de Jong PT, Stricker BH. Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement. BMJ 2003;326:255–6. · DOI
  46. Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology 1994;101:1851–5. · DOI · Paper page
  47. Wolfs RC, Borger PH, Ramrattan RS, et al. Changing views on open-angle glaucoma: definitions and prevalences: the Rotterdam Study. Invest Ophthalmol Vis Sci 2000;41:3309–21.
  48. Dielemans I, Vingerling JR, Algra D, Hofman A, Grobbee DE, de Jong PT. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population. The Rotterdam Study. Ophthalmology 1995;102:54–60. · doi:10.1016/s0161-6420(95)31054-8
  49. Wolfs RC, Klaver CC, Ramrattan RS, van Duijn CM, Hofman A, de Jong PT. Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Arch Ophthalmol 1998;116:1640–5. · DOI · Paper page
  50. de Voogd S, Ikram MK, Wolfs RC, Jansonius NM, Hofman A, de Jong PT. Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study. Ophthalmology 2005;112:1487–93. · DOI
  51. Skenduli-Bala E, de Voogd S, Wolfs RC, et al. Causes of incident visual field loss in a general elderly population: the Rotterdam study. Arch Ophthalmol 2005;123:233–8. · DOI
  52. Ikram MK, de Jong FJ, Vingerling JR, et al. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci 2004;45:2129–34. · DOI · Paper page
  53. Rietveld I, Ikram MK, Vingerling JR, et al. An igf-I gene polymorphism modifies the risk of diabetic retinopathy. Diabetes 2006;55:2387–91. · DOI
  54. Ikram MK, de Jong FJ, Bos MJ, et al. Retinal vessel diameters and risk of stroke: the Rotterdam Study. Neurology 2006;66:1339–43. · DOI · Paper page
  55. Ikram MK, Witteman JC, Vingerling JR, Breteler MM, Hofman A, de Jong PT. Retinal vessel diameters and risk of hypertension: the Rotterdam Study. Hypertension 2006;47:189–94. · DOI · Paper page
  56. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367–74. · DOI · Paper page
  57. Hubbard LD, Brothers RJ, King WN, et al. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 1999;106:2269–80. · DOI · Paper page
  58. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J, de Groot LC, Hofman A, Witteman JC, van Leeuwen JP, Breteler MM, Lips P, Pols HA, Uitterlinden AG. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004;350:2033–41. · DOI · Paper page
  59. Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 2002;359:1036–7. · DOI · Paper page
  60. van Meurs JBJ, Schuit SCE, Weel AEAM, van der Klift M, Bergink AP, Arp PP, Colin EM, Fang Y, Hofman A, van Duijn CM, van Leeuwen JPTM, Pols HAP, Uitterlinden AG. Association of 5′ estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area, and fracture risk. Hum Mol Genet 2003;12:1745–54. · DOI
  61. Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, de Maat MP, Boekhoorn SS, Vingerling JR, Hofman A, Oostra BA, Uitterlinden AG, Stijnen T, van Duijn CM, de Jong PT. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA 2006;296:301–9. · DOI · Paper page
  62. Aarnoudse AJLHJ, Newton-Cheh C, de Bakker PIW, Straus SMJM, Kors JA, Hofman A, Uitterlinden AG, Witteman JCM, Stricker BHCh. A common NOS1AP variant is associated with longer QTc interval and sudden cardiac death: the Rotterdam Study. Circulation 2007;116:10–6. · DOI
  63. Fang Y, van Meurs JB, d’Alesio A, Jhamai M, Zhao H, Rivadeneira F, Hofman A, van Leeuwen JP, Jehan F, Pols HA, Uitterlinden AG. Promoter and 3′ UTR haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam Study Am J Hum Genet 2005;77:807–23. · DOI · Paper page
  64. Feenstra J, Heerdink ER, Grobbee DE, Stricker BHCh. Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure. Arch Int Med 2002;162:265–70. · DOI · Paper page
  65. Straus SM, Kors JA, de Bruin ML, van der Hooft CS, Hofman A, Heeringa J, Deckers JW, Kingma JH, Sturkenboom JCM, Stricker BHCh, Witteman JCM. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006;47:362–7. · DOI · Paper page
  66. Van der Hooft CS, Heeringa J, Brusselle GG, Hofman A, Witteman JCM, Kingma JH, Sturkenboom MCJM, Stricker BHCh. Corticosteroids and the risk of atrial fibrillation. Arch Int Med 2006;165:1016–20. · DOI · Paper page
  67. Schoofs MWCJ, van der Klift M, Hofman A, de Laet CEDH, Herings RMC, Stijnen Th, Pols HAP, Stricker BHCh. Thiazide diuretics and the risk for hip fracture. Ann Intern Med 2003;139:476–82. · DOI · Paper page
  68. Schoofs MW, Sturkenboom MCJM, van der Klift M, Hofman A, Pols HA, Stricker BHCh. HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Miner Res 2004;19:1525–30. · DOI
  69. Reijman M, Bierma-Zeinstra SM, Pols HAP, Koes BW, Stricker BHCh, Hazes JM. Is there an association between the use of different types of NSAIDs and radiologic progression of osteoarthritis ? The Rotterdam Study. Arthritis Rheum 2005;52:3137–42. · DOI
  70. Van Leeuwen R, Vingerling JR, Hofman A, de Jong PTVM, Stricker BHCh. Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement. BMJ 2003;326:255–6. · DOI
  71. Visser LE, Penning-van Beest FJA, Kasbergen AAH, De Smet PAGM, Vulto AG, Hofman A, Stricker BHCh. Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulants. Clin Pharmacol Ther 2002;71:496–502. · DOI
  72. Visser LE, Penning-van Beest FJA, Kasbergen HAA, De Smet PAGM, Vulto AG, Hofman A, Stricker BHCh. Overanticoagulation associated with combined use of antibacterial agents and acenocoumarol or phenprocoumon anticoagulants. Thromb Haemost 2002;88:705–10. · DOI
  73. Visser LE, van Vliet M, van Schaik RHN, Kasbergen AAH, de Smet PAGM, Vulto AG, Hofman A, van Duijn CM, Stricker BHCh. The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon. Pharmacogenetics 2004;14:27–33. · DOI
  74. Visser LE, Penning-van Beest FJ, Wilson JHP, Vulto AG, Kasbergen AA, de Smet PAGM, Hofman A, Stricker BHCh. Overanticoagulation associated with combined use of lactulose and coumarin anticoagulants. Br J Clin Pharmacol 2004;57:522–4. · DOI
  75. Visser LE, van Schaik RH, van Vliet M, Trienekens PH, de Smet PAGM, Vulto AG, Hofman A, van Duijn CM, Stricker BHCh. The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon. Thromb Haemost 2004;92:61–6. · DOI
  76. Visser LE, Bleumink GS, Trienekens PH, Vulto AG, Hofman A, Stricker BHCh. The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants. Br J Haematol 2004;127:85–9. · DOI
  77. Visser LE, van Schaik RHN, van Vliet M, Trienekens PH, de Smet PAGM, Vulto AG, Hofman A, van Duijn CM, Stricker BHCh. Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants. Clin Pharmacol Ther 2005;77:479–85. · DOI
  78. Bleumink GS, Schut AF, Sturkenboom MC, van Duijn CM, Deckers JW, Hofman A, Kingma JH, Witteman JC, Stricker BHCh. Mortality in patients with hypertension on ACE-inhibitor treatment is influenced by the ACE I/D polymorphism. Pharmacogenet Genomics 2005;15:75–81. · DOI
  79. Visser LE, Trienekens PH, de Smet PAGM, Vulto AG, Hofman A, van Duijn CM, Stricker BHCh. Patients with an ApoE epsilon4 allele require lower doses of coumarin anticoagulants. Pharmacogenet Genomics 2005;15:69–74. · DOI

Cited by

See all 1,395

Metadata

Authors
Hofman, A., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A., Stricker, B. H. C., Tiemeier, H., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M.
Venue
European Journal of Epidemiology
Publisher
Springer Science and Business Media LLC
Published
2007-10-23
Volume
22
Issue
11
Pages
819-829
ISSN
  • 0393-2990 (ISSN-L)
  • 1573-7284
DOI
10.1007/s10654-007-9199-x
OpenAlex
W2109252993
Cited by
1,395
References
41
FWCI
54.22
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Rotterdam Study: objectives and design update. https://app.cochat.ai/papers/10.1007/s10654-007-9199-x
The paper
Hofman, A., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A., Stricker, B. H. C., Tiemeier, H., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M. (2007). The Rotterdam Study: objectives and design update. European Journal of Epidemiology. https://doi.org/10.1007/s10654-007-9199-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.